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Abstract: 
The existence of pharmaceuticals and illicit drugs (PIDs) in environmental waters has 
led many analytical chemists to develop screening methods for monitoring purposes. 
Water samples can contain a huge number of possible contaminants, commonly at low 
concentrations, which makes their detection and identification problematic. Liquid 
chromatography coupled with high resolution mass spectrometry (LC-HRMS) has 
proven itself effective in the screening of environmental contaminants. The present 
work investigates the use of the most popular HRMS instruments, quadrupole time-of-
flight and linear trap quadrupole-Orbitrap, from two different laboratories. A suspect 
screening for PIDs was carried out on wastewater (influent and effluent) and surface 
water samples from Castellón, Eastern Spain, and Cremona, Northern Italy, 
incorporating a database of 107 PIDs (including 220 fragment ions). A comparison 
between the findings of both instruments and of the samples was made which highlights 
the advantages and drawbacks of the strategies applied in each case.  In total, 28 
compounds were detected and/or identified by either/both instruments with irbesartan, 
valsartan, benzoylecgonine and caffeine being the most commonly found compounds 
across all samples.  
 
Key words: Liquid Chromatography, Screening, Pharmaceuticals, Illicit Drugs, High 
Resolution Mass Spectrometry  
  
Page	  3	  of	  25	  
	  
 1. Introduction 
The presence of pharmaceuticals and illicit drugs (PIDs) in environmental waters has 
become more apparent in the past decade due to the improvements in selectivity and 
sensitivity of modern analytical techniques. PIDs are continuously excreted or disposed 
into the sewer systems as the unaltered parent compound or as metabolites (Richardson, 
2012). Compounds of the most concern in the environment are those found with high 
concentrations and those that have been proven detrimental to the aquatic life; in fact, 
for several antibiotics, hormones and pharmaceuticals, some effects have been shown  
(Brozinski et al., 2013; Kümmerer, 2009; Li, 2014).  Various pharmaceuticals, 
antibiotics and illicit drugs and metabolites such as acetaminophen, carbamazepine, 
diclofenac, ciprofloxacin and benzoylecgonine,  are frequently detected in waters and 
are considered a potential threat (Li, 2014; Luo et al., 2014; Pal et al., 2013).  
Nowadays, data processing is often the most time-consuming step when screening a 
large number compounds. A fast screening method, referring to the easy searching of 
PIDs by software following full scan acquisition by high resolution mass spectrometry 
(HRMS),  is therefore of great interest in order to gain a complete overview of possible 
contaminants and their fate in the aquatic environment. Another time consuming step is 
sample preparation. Important improvements in sensitivity and specificity of recent 
instrumentation have facilitated the direct injection of the samples (Anumol and Snyder, 
2015; Backe and Field, 2012).  
HRMS instruments, such as quadrupole time-of-flight (QTOF) MS and Orbitrap MS,  
provide high quality data by combining full spectrum mass data with high mass 
resolution and mass accuracy (Krauss et al., 2010). Powerful deconvolution software is 
required to facilitate sample analysis for these instruments. Each manufacturer has its 
own software, such as ChromaLynx (Waters) and TraceFinder (ThermoScientific). 
These systems allow post-target analysis, whereby the presence of an unlimited number 
of contaminants can be investigated through the addition of empirical or theoretical 
compound databases, without depending on the pre-selection of analytes or having 
reference standards available (Hernández et al., 2014). In the processing of numerous 
samples and compounds, these programs undeniably save time, and hence are a 
necessity for a large screening of environmental contaminants.  
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It is difficult to compare the individual HRMS mass analysers (i.e. TOF and Orbitrap), 
but each hold distinct advantages. The main advantage of Orbitrap is its high mass 
resolving power (>100000 full width at half maximum (FWHM)). In complex 
environmental matrices, co-elution of analytes with matrix interferences can result in 
ambiguous peaks. By utilising the ultra-high resolution capabilities, compounds with a 
very similar exact mass can be easily differentiated (Hernández et al., 2012). However, 
its main drawback is its slower scanning speed and inverse relationship to resolution. 
Conversely, the higher scanning speed of TOF enables it to be used with the highly 
efficient separation technique ultra-high performance liquid chromatography (UHPLC), 
resulting in shorter run times and improved sensitivity. (Hernández et al., 2014) 
To achieve better performance such as higher sensitivity and mass resolving power, 
manufacturers have implemented hybrid mass spectrometers, two of which are used in 
the current work: quadrupole-TOF (QTOF) and linear trap quadrupole-Orbitrap (LTQ-
Orbitrap). The UHPLC capabilities are exemplified when QTOF is employed in MSE 
mode, which involves the simultaneous acquisition of exact mass data at low and high 
collision energy (Hernández et al., 2011). At low energy, information pertaining to the 
non-fragmented (de)protonated molecule is obtained, while at high energy, information 
regarding the fragments is attained. This means that all required information is obtained 
in just one injection. LTQ Orbitrap combines the tandem mass spectrometric capability 
of the LTQ with the high resolution and mass accuracy capability of the Fourier 
Transform (FT) Orbitrap (de Voogt et al., 2011). LTQ-Orbitrap is operated in data 
dependent acquisition (DDA) mode whereby MS and MSn spectra are obtained 
simultaneously, however the number of compounds able to be acquired is limited and 
therefore may require subsequent injections.   Some studies have been made on the 
identification of organic pollutants in water by QTOF MS (Gómez et al., 2010; 
Gonzalez-Mariño et al., 2012; Hernández et al., 2011; Ibáñez et al., 2009) and LTQ 
Orbitrap MS (Kosma et al., 2014; Pinhancos et al., 2011; Wille et al., 2011).  
This work derives from a collaborative study between two laboratories within the ITN 
Marie Curie SEWPROF network (“SEWPROF ITN: A new paradigm in drug use and 
human health risk assessment: Sewage profiling at the community level,” n.d.). The aim 
was to perform a screening of PIDs in waste- and environmental waters using two 
different LC-HRMS systems (UHPLC-QTOF MS and Capillary-LC-LTQ-Orbitrap MS) 
available in our laboratories. Normally, a given laboratory would use just one of the 
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instruments, but as both have a great capability for screening and identification, in this 
work we pursued the comparison of data from the same analyzed samples (samples 
collected from Spain and Italy).	   In addition, the complementary use allows true 
confirmation of the compound in the sample (Krauss et al., 2010). Although the same 
compounds were initially searched, the different acquisition modes may additionally 
detect other contaminants, and widen the scope of the screening. It is worth noting that a 
comparison of the instruments or methods used was not pursued, rather their use to 
ratify the findings of the other instrument. In this way, on the basis of the results of the 
present paper, the methodologies applied by each laboratory could be validated by the 
results obtained by the other laboratory in terms of qualitative analysis.  When 
performing the screening, four criteria were used based on the level of confidence and 
on the availability of reference standards. Numerous compounds were detected and 
identified from samples of different origin and matrix composition (influent and effluent 
urban wastewater, surface water). All samples, independently of they were collected 
from Spain or from Italy, were analysed by both HRMS instruments (Orbitrap in Milan, 
and TOF in Castellon), which supports the feasibility and robustness of high-resolution 
screening of PIDs in complex environmental samples. 
2. Experimental  
2.1 Chemicals and Reagents 
For information regarding the reference standards used for QTOF and LTQ Orbitrap 
analysis (see Electronic Supplementary Material (ESM), Section 2.1).  
HPLC-grade methanol (MeOH), ammonia solution (25%), formic acid (HCOOH, 98–
100%) were acquired from Scharlau (Barcelona, Spain) and acetonitrile for LC-MS, 
from Riedel de Haen (Seelze, Germany). HPLC-grade water was obtained by purifying 
demineralised water in a Milli-Q plus system from Millipore (Bedford, MA, USA). SPE 
cartridges used were Oasis HLB 3 mL (60 mg) from Waters (Milford, MA, USA). 0.45 
µm mixed cellulose ester membrane filters and 1.6 µm GF/A glass microfiber filters 
were purchased from Whatman (Kent, UK).  
2.2 Samples: 
2.2.1 Influent and effluent wastewater  
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In total, 18 wastewater samples (nine influent wastewater (IWW) and effluent 
wastewater (EWW)) were taken from a WWTP in Castellón, Eastern Spain, and 
Cremona, Northern Italy.  The 24h composite IWW and EWW samples were collected 
over seven consecutive days in March 2014 (Castellón) and two consecutive days in 
May (Cremona) in high density polystyrene bottles and directly transported to the lab 
where they were immediately filtered and stored in the dark at −20 °C until analysis.  
2.2.2 Surface waters 
Five grab samples were taken from the Castellon region, Eastern Spain:  Almenara, 
Burriana Clot, Nules, and two sites in Albufera Natural Park.  All samples were stored 
in high density polystyrene bottles at 4º C for less than 48 hours, until sample treatment. 
2.3 Sample Treatment  
Prior to SPE, Spanish WW samples were vacuum filtered through 0.45µm mixed 
cellulose ester membrane filters and the Italian samples were filtered through 1.6 µm 
GF/A glass microfiber filters. Surface water samples were not filtered. Subsequently, 
100mL of the samples (IWW was four times diluted with MilliQ water, i.e. 25mL 
sample in 100mL) were extracted using SPE cartridges (Oasis HLB), which were first 
conditioned by washing and rinsing with 6 mL of MeOH and 6 mL of Milli-Q water. 
Samples were percolated through the cartridges by gravity (flow rate around 3mL 
min−1), and vacuum dried for approximately 15 min. After elution with methanol, 
extracts were evaporated to dryness at 35 °C under a gentle stream of nitrogen and 
reconstructed in 1 mL of 10% methanol aqueous solution (Bijlsma et al., 2014) .  Two 
0.5mL aliquots were taken from the extract, one each for the QTOF and Orbitrap 
analyses. UHPLC-MS QTOF analyses were performed by injecting 20µL of the final 
extract into the system. Capillary-LC-LTQ-Orbitrap analyses were performed by 
injecting 2µL of the final extract into the system. 
2.4 Instrumentation 
2.4.1 Ultra High Performance Liquid Chromatography –QTOF- Mass Spectrometry  
A Waters Acquity UPLC system (Waters, Milford, MA, USA) was interfaced to a 
hybrid quadrupole-orthogonal acceleration-TOF mass spectrometer (XEVO G2 QTOF, 
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Waters Micromass, Manchester, UK), using a Z-Spray ESI interface operating in 
positive ion mode.  
The chromatographic separation was performed using an Acquity UPLC BEH C18 
1.7  µm particle size column 100  ×  2.1  mm (Waters) at a flow rate of 300µl/min. The 
mobile phases used were A  =  H2O and B  =  MeOH (both with 0.01% HCOOH). The 
total run time was 18 minutes. The initial percentage of B was 10%, which was linearly 
increased to 90% in 14  min, followed by a 2  min isocratic period and, then, returned to 
initial conditions during 2  min. Nitrogen was used as drying gas and nebulizing gas.  
MS data were acquired over an m/z range of 50–1000. A capillary voltage of 0.7  kV and 
cone voltage of 20  V were used. Collision gas was argon 99.995% (Praxair, Valencia, 
Spain). The desolvation temperature was set to 600  °C, and the source temperature to 
135  °C. The column temperature was set to 40  °C. 
For MSE experiments, two acquisition functions with different collision energies were 
created. The low energy function (LE), selecting a collision energy of 4  eV, and the 
high energy (HE) function, with a collision energy ramp ranging from 15 to 40  eV in 
order to obtain a greater range of fragment ions. The total scan time was 0.4  s. 
QTOF MS data was processed using ChromaLynx XS application manager (within 
MassLynx v 4.1; Waters Corporation). The following parameters were used:  Target RT 
Tolerance (1.50min) from empirical retention time (obtained from injecting standards), 
Mass tolerance 0.020Da (for positive ID 0.010 Da), Peak width at 5% height: 6 seconds, 
Peak-to-peak baseline noise: 1000, Threshold absolute area: 250 for SW, 500 for IWW 
and EWW.  
2.4.2 Liquid Chromatography- LTQ Obritrap Mass Spectrometry 
Mass spectrometry analysis was performed on a high resolution LTQ-Orbitrap XL 
instrument, interfaced to the HPLC system through a Desorption Electrospray Ionisation 
(DESI) source, used in nano-spray mode (Prosolia, Indianapolis, IN, USA). The 
instrument was operated at 60,000 resolution for full MS scans and at 15,000 resolution 
for MS2 scans, after CID fragmentation in the linear ion trap cell. The scan time was 
0.85 seconds and the cycle time was 4.8 seconds. Every sample was analysed in a data-
dependent acquisition mode (DDA), in which the first data event was a full scan MS, 
while the following 4 data events were MS2 scans of the 4 most intense ions recorded in 
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the first event. A subsequent injection in MS/MS mode was made to find further 
fragments, based on target lists (see Section 3.1).    
The chromatographic separation was performed using a Zorbax SB-C18 5µm particle 
size column 150 × 0.5mm (Agilent Technologies) at a flow rate of 10µL/min. The 
mobile phases used were A: H2O (0.1% HCOOH) and B: Acetonitrile. The total run 
time was 46 minutes. The initial percentage of B was 1% and was linearly increased to 
99% in 24 minutes, followed by a 10 minute isocratic period and then reduced back to 
initial conditions in 2 minutes which were kept for 10 minutes (post-run) to equilibrate 
the column.   
Processing of the Orbitrap data was made using TraceFinder EFS and QualBrowser 
software (Thermo Scientific). The following parameters were used: [M+H]+ intensity 
(5,000), signal-to-noise ratio threshold (=5), retention time window override for 
confirmation (90 seconds), fragment intensity (1,000 with 10ppm mass tolerance); 
isotopic pattern (60% fit threshold, 5ppm mass deviation, 10% intensity deviation); 
library search (20% score threshold) using the Toxicology HCD 30-70-110eV Library 
of Thermo Scientific. This library contained the information of 1700 compounds, but 
not all PIDs compounds selected in our list were included in the Library. 
2.5 Criteria for detection/identification 
Up to four levels were considered for detection and identification of the compounds 
based on the availability of reference standard and on the reliability of the data obtained. 
These levels were derived from a recent article exploring the means of identification of 
small molecules (Schymanski et al., 2014) and the European Commission Decision 
2002/657/EC for the confirmation of contaminants in samples of animal origin, 
commonly employed in environmental studies. The criteria used included the presence 
of the protonated molecule at accurate mass, fragment ion(s) at accurate mass, retention 
time and isotopic pattern.     
2.5.1 Selected criteria for QTOF MS 
The standards injected on each instrument were those available at the respective 
laboratories (See SI Section 2.1). They may be different; however, as explained above, a 
comparison between the labs is not proposed.  
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Standard available (11 illicit drug and 61 pharmaceutical standards, see SI section 2.1)  
1. Detection: protonated molecule [M+H]+ at accurate mass (<5ppm), and retention 
time in agreement with reference standard (±2.5%).  
2. Identification: protonated molecule [M+H]+ at accurate mass (<5ppm), at least one 
fragment ion, commonly in HE (<5ppm), retention time agreement with reference 
standard (±2.5%).  
Standard not available: 
3. Tentative detection (potential positive): presence in the extracted ion chromatogram 
of the protonated molecule [M+H]+ at accurate mass (<10 ppm), typically in the LE 
function  
4. Tentative identification: protonated molecule [M+H]+ at accurate mass (<10ppm), 
and at least one fragment ion, commonly in HE function (<10 ppm), in agreement 
with data reported from literature or online databases. 
2.5.2 Selected criteria for LTQ-Orbitrap MS 
Standard available (25 illicit drug and 27 pharmaceutical standards, see SI section 
2.1)  
1. Detection: protonated molecule [M+H]+ at accurate mass (<5 ppm), retention time 
agreement with standard (±2.5%), isotopic pattern (60% fit threshold, 5ppm mass 
deviation, 10% intensity deviation) 
2. Identification: protonated molecule [M+H]+ at accurate mass (<5 ppm, intensity 
>5000), at least one fragment ion in MS/MS (intensity > 1000, <10 ppm), retention 
time agreement with standard ((±2.5%), isotopic pattern (60% fit threshold, 5 ppm 
mass deviation, 10% intensity deviation); library search (20% score threshold) using 
the Toxicology HCD 30-70-110eV Library.  
Standard not available 
3. Tentative detection (potential positive): protonated molecule [M+H]+ at accurate 
mass (<10ppm, intensity >5000) 
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4. Tentative identification: protonated molecule [M+H]+ at accurate mass (<10ppm 
intensity >5000), at least one fragment ion (intensity > 1,000, <10ppm mass 
tolerance), comparable with literature or online databases, isotopic pattern (60% fit 
threshold, 5ppm mass deviation, 10% intensity deviation).  
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3. Results and Discussion 
The methodologies followed for these analyses are based on the generic configuration 
employed by each laboratory. We acknowledge that the Orbitrap configuration is not 
optimal for screening of PIDs in water, as its use is primarily in the field of proteomics, 
which justifies the use of a capillary column and DESI source. Therefore, we do not 
intend to show a comprehensive comparison of the instruments, but to determine 
whether both laboratories and instruments can detect and identify the same compounds 
using their individual workflows.  
Furthermore, in this work, we do not set out to perform a wide-scope screening of a 
huge number of compounds, but rather to focus on a limited number of well-known, 
widely detected PIDs in wastewater to test the usefulness of the different approaches 
and instruments used and also to compare the countries.    
3.1 Selection of PIDs 
The compounds to be investigated were initially based on a database similar to that 
made by Diaz et al. (Díaz et al., 2011), but focussing solely on pharmaceuticals and 
illicit drugs. The database contained the compound name, associated fragments (if 
known), retention time (if standard was available) and molecular formula. A qualitative 
validation was previously performed using a similar analytical procedure based on LC-
QTOF MS measurements, and the empirical screening detection limits (SDL) and limits 
of identification (LOI) in different type of water samples were established for some of 
the compounds included in the present work. For most compounds evaluated SDLs 
were 0.02 or 0.1 µg/L (Diaz et al., 2013; Hernández et al., 2015). For compounds where 
no standards were available, the database included data regarding fragment ions and 
molecular formula from literature or online databases such as MassBank (Horai et al., 
2010).  
To ensure national significance, compounds found from previous studies of these 
regions were investigated and added to the database (Spain (Gracia-Lor et al., 2011, 
2010) ; Italy (Al Aukidy et al., 2012; Zuccato et al., 2010, 2006)). In total, 107 PIDs and 
220 fragment ions were incorporated in the database (See ESM Table S1).  
As stated in Section 2.4.2, each sample was injected twice in the Orbitrap. The first 
injection enabled full-scan acquisition. In this data, the original database of 107 PIDs 
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was searched using TraceFinder and potential positive compounds were then selected, 
based on retention time and exact mass, as unfortunately the expected fragment ion 
information of the targeted compounds was not among the four most intense ions 
detected within the data events. These “positives” were then grouped into target lists, 
according to whether they were found in the Spanish (40 compounds) or Italian (52 
compounds) samples (See ESM Tables S2 and S3). The second injection incorporated 
these target lists, thereby enabling their product ions to be seen.  
Within the software of the QTOF and Orbitrap, a threshold was given for intensity and 
mass error, outside which peaks were disregarded as noise. The majority of compounds 
were able to be automatically identified or detected thanks to the ChromaLynx and 
TraceFinder software. However, in some cases, some compounds were only able to be 
detected (i.e. no fragment ions found). This demonstrated the complementariness of the 
instruments: when one instrument was solely able to detect a compound (only the 
precursor ion found), the other was able to at least tentatively identify the compound 
with fragments. The raw data of both instruments was manually inspected in these 
situations to ratify the fragments (see Table 1).  This secondary examination also 
reduced the possibility that one of the software had erroneously eliminated some 
compounds. The raw data investigations were only required for a small number of 
compounds, which is testament to the utility of the software. However, by decreasing 
the identification thresholds used, the need for manual inspection could be avoided, 
which is especially recommended for wide-scope screening methods incorporating 
thousands of compounds.  
3.2 Comparison of results from Spain and Italy 
Table 1 shows the number of compounds identified (according to identification criteria 
2 and 4, from Section 2.5) and detected (according to detection criteria 1 and 3, from 
Section 2.5) in each sample. In general, more compounds were able to be identified (up 
to 18) or detected (up to 25) in the Spanish samples than the Italian. However, some 
compounds were only able to be detected and not identified in some samples, due to 
low analyte concentration. For example, ofloxacin in Castellón IWW was identified in 
only three samples by QTOF, but detected in the all, while it was identified in all 
samples by Orbitrap. In addition, trimethoprim was only detected in all Spanish and 
Italian EWW samples by both instruments. These results show that these compounds 
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were likely present in all the detected samples, but unable to be identified due to a 
combination of their low concentrations and the difference in MS/MS acquisition 
between the instruments.  
There is little national difference, with just cotinine, gabapentin, oxazepam, temazepam 
and a metabolite of metamizole (4-aminoantipyrine), not identified in the Italian 
samples. This is not to say that these compounds are not in the samples, rather that their 
concentration is lower than that necessary for detection or identification. In fact, 4-
aminoantipyrine was the only compound in the aforementioned list not detected in at 
least one of the Italian samples. Metamizole (also known as dipyrone) is a non-steroidal 
anti-inflammatory drug. In some countries such as Sweden, UK, Canada or United 
States metamizole has been banned or restricted for human use due to its association 
with diseases like agranulocytosis (Gómez et al., 2008). However in many other 
countries including Spain and Italy it can be purchased without a medical prescription 
(“Metamizolo: una lunga storia tra luci ed ombre,” n.d.). Metamizole is a widely 
consumed pharmaceutical in Spain and some years ago it was among the ten most 
consumed pharmaceuticals (considering the amount of prescriptions), according to the 
information published by the Spanish Ministry of Health (Prescription data: IT del 
Sistema Nacional de Salud Volumen 30, 2006). In Italy, metamizole is also highly 
consumed but is not included in the list of the most consumed pharmaceuticals 
(Farmaco, 2013). This apparent difference in consumption could reflect the difference 
in its detection in the samples of Spain and Italy.  
The most commonly detected compounds mirrored those found in similar studies 
(Gracia-Lor et al., 2012; Hernández et al., 2011; Zuccato et al., 2010, 2006). Irbesartan, 
ofloxacin, sulfamethoxazole and valsartan were identified in IWW and EWW of both 
Spain and Italy. Caffeine, irbesartan, valsartan and venlafaxine were also found in a 
high enough concentration in surface water to be identified by at least one of the two 
instruments. Several previous studies have also shown that these compounds are not 
fully removed in WWTPs and can be present in surface waters (Ferrer and Thurman, 
2012; Kasprzyk-Hordern et al., 2007; Li, 2014; Luo et al., 2014), which  indicates that 
further investigation into their potential fate and harm to the environment is necessary.    
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3.3 Use of QTOF and LTQ-Orbitrap 
 
There was little difference between the number of compounds able to be identified by 
QTOF and Orbitrap. However, there are some discrepancies between the numbers of 
compounds in each sample that are identified by each instrument. For example, 
naproxen is identified using the software in all seven Spanish IWW samples by QTOF, 
while in only four by the Orbitrap. Alternatively, with Orbitrap, bezafibrate and 
morphine are identified in seven and four Spanish EWW samples respectively, but in 
none by QTOF. In both cases, the compounds were detected and compared with 
standards. Figures 1 and 2 show the examples of naproxen and bezafibrate respectively.  
 
Figure 1 provides an example of raw data investigation, touched upon in Section 3.1. In 
an IWW sample, the QTOF data was searched with ChromaLynx and able to identify 
naproxen, without having to refer to the raw data (Figure 1 (a)). The protonated 
molecule (231.1017) and primary fragment ion (185.0971) were seen in the LE and HE 
spectra within the thresholds of mass error for identification. To gain further confidence 
in this finding, the Orbitrap data was searched with TraceFinder. However, the software 
could not identify naproxen in this IWW sample. A subsequent search of the raw data 
by QualBrowser revealed its presence (Figure 1 (b)).  
 
Figure 2 exemplifies the compatibility of the two HRMS instruments. ChromaLynx 
was unable to identify bezafibrate through the use of fragments, so the raw data was 
checked (Figure 2 (a), right). Again, only the precursor was able to be found. A 
comparison with the standard is also made, showing the three fragments of 316.1105, 
276.0788 and 138.9947 (Figure 2 (a), left). These fragments were searched in the HE 
spectrum of the sample, but no suitable peaks were found (Figure 2 (a), right). It was 
thought that bezafibrate was below the detection threshold for the QTOF, which has a 
known relationship between intensity and mass error (i.e. at low concentration, the mass 
error would be high) and therefore at a low concentration, the fragment ions would fall 
outside the given mass error threshold. Conversely, Orbitrap is able to maintain its mass 
accuracy, even at low concentrations. Hence, for the same sample, using Orbitrap, 
bezafibrate was able to be identified with all three fragments (Figure 2 (b), right).  
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A further example of the use of these instruments was in the identification of 
benzoylecgonine in an IWW sample. The protonated ion was seen in the QTOF data 
with a mass error of 0.07 ppm, a retention time of Δ 0.01 min. from that of the standard, 
and only one fragment with a mass error of 6.31ppm – just outside the criteria used for 
identification (see Section 2.5). Although we were confident this was in fact 
benzoylecgonine, and did tentatively assign it as “identified”, it did not quite fulfil our 
set requirements.  To appease our doubts, we also checked the Orbitrap data. Here, the 
protonated molecule and fragment ion were found within the threshold of 5ppm and the 
retention time differed by 0.1 minutes from the standard. The isotopic pattern fit was 
above the 60% threshold and the library search score of 50%, above the threshold set. 
Therefore, full confidence in identification was gained for this compound. Although 
identification could also have been possible by manually scouring the raw data, as the 
fragment ion was only just outside the given threshold it was thought better to compare 
with the Orbitrap data.   
 
The mere fact that further information can be gleaned from these two instruments shows 
their complementariness. The SANCO guidelines on analytical quality control and 
validation procedures for pesticide residues analysis in food and feed (“Guidance 
document on analytical quality control and validation procedures for pesticides residues 
in food and feed,” 2013), which are also applied for environmental samples in the 
absence of specific guidelines for the environmental field, state that “confirmation is the 
combination of  two or more analyses that are in agreement with each other.” The use of 
two HRMS instruments thus follows these SANCO guidelines, and as shown in Section 
3.3 and Table 1, confirmation (i.e. identification) of numerous compounds is made. The 
examples given thus demonstrate the complementary use of QTOF and Orbitrap in the 
suspect screening of PIDs in environmental and wastewaters.  
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4. Conclusions: 
In this paper, two LC-HRMS instruments (QTOF and LTQ-Orbitrap) used in different 
laboratories were used to screen for PIDs in samples of wastewater and surface water 
from Spain and Italy. A database of compounds frequently detected in water was used 
by both instruments, incorporating compounds of national significance. The samples 
were first investigated through the use of the manufacturer’s software (ChromaLynx or 
TraceFinder), which allowed the detection of various compounds and in some cases the 
positive identification with fragment ions. Following this strategy, up to 18 compounds 
were identified with fragment ions across both instruments, while 28 compounds were 
at least detected (only the most abundant ion present) across all samples. In particular 
cases where identification was not automatic using software, the raw data was manually 
investigated. This was only necessary for a few compounds and occurred when the 
compound was detected but could not be identified. There was no significant difference 
between the countries, the metamizole metabolite, 4-aminoantipyrine, being the only 
compound found solely in Spanish waters.  
The screening results obtained by QTOF MS and LTQ-Orbitrap MS were very similar, 
with the number of compounds detected/identified only differing by up to four across all 
samples. Although the objective of this work was not to compare the methods, rather 
the results in terms of detection and reliable identification, it is worth noting that the 
LTQ-Orbitrap was able to identify a few more compounds without having to manually 
search for fragment ions. On the whole, this paper shows that these powerful 
instruments, used in these configurations, are suitable for the detection and 
identification of numerous environmental contaminants in waste and environmental 
waters. The general agreement in data obtained will serve to validate the methodologies 




Page	  17	  of	  25	  
	  
Acknowledgements 
R. Bade, N. I. Rousis and E. Gracia-Lor acknowledge the European Union's 
International Training Network SEWPROF [Marie Curie-FP7-PEOPLE Grant #317205] 
for their Early Stage Researcher (R. Bade and N. I. Rousis) and Experienced Researcher 
(E. Gracia-Lor) contracts. The financial support from the Spanish Ministry of Economy 
and Competitiveness (Ref CTQ2012-36189), and Generalitat Valenciana, Spain 
(research group of excellence PROMETEO II/2014/023; ISIC 2012/016) is also 
acknowledged.	  	  
We would like to thank Thermo Scientific who provided the software Trace Finder and 
particularly Claudia Martins for technical support. 
 
Conflict of Interest 
The authors declare that they have no conflict of interest. 
Page	  18	  of	  25	  
	  
References 
Al Aukidy, M., Verlicchi, P., Jelic, a, Petrovic, M., Barcelò, D., 2012. Monitoring release of 
pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP 
effluents and their receiving bodies in the Po Valley, Italy. Sci. Total Environ. 438, 15–25. 
doi:10.1016/j.scitotenv.2012.08.061 
Anumol, T., Snyder, S. a., 2015. Rapid analysis of trace organic compounds in water by 
automated online solid-phase extraction coupled to liquid chromatography–tandem mass 
spectrometry. Talanta 132, 77–86. doi:10.1016/j.talanta.2014.08.011 
Backe, W.J., Field, J. a., 2012. Is SPE necessary for environmental analysis? A quantitative 
comparison of matrix effects from large-volume injection and solid-phase extraction based 
methods. Environ. Sci. Technol. 46, 6750–6758. doi:10.1021/es300235z 
Bijlsma, L., Beltrán, E., Boix, C., Sancho, J. V, Hernández, F., 2014. Improvements in 
analytical methodology for the determination of frequently consumed illicit drugs in urban 
wastewater. Anal. Bioanal. Chem. 406, 4261–72. doi:10.1007/s00216-014-7818-4 
Brozinski, J., Lahti, M., Meierjohann, A., Oikari, A., Kronberg, L., 2013. The Anti-
Inflammatory Drugs Diclofenac, Naproxen and Ibuprofen are found in the Bile of Wild 
Fish Caught Downstream of a Wastewater Treatment Plant. Environ. Sci. Technol. 47, 
342–348. doi:10.1021/es303013j 
De Voogt, P., Emke, E., Helmus, R., Panteliadis, P., van Leerdam, J.A., 2011. Determination of 
illicit drugs in the water cycle by LC-Orbtitrap MS, in: Castiglioni, S., Zuccato, E., 
Fanelli, R. (Eds.), Illicit Drugs in the Environment: Occurence, Analysis, and Fate Using 
Mass Spectrometry. John Wiley & Sons, Ltd., pp. 87–114. 
Diaz, R., Ibáñez, M., Sancho, J. V, Hernández, F., 2013. Qualitative validation of a liquid 
chromatography-quadrupole-time of flight mass spectrometry screening method for 
organic pollutants in waters. J. Chromatogr. A 1276, 47–57. 
doi:10.1016/j.chroma.2012.12.030 
Díaz, R., Ibáñez, M., Sancho, J. V, Hernández, F., 2011. Building an empirical mass spectra 
library for screening of organic pollutants by ultra-high-pressure liquid 
chromatography/hybrid quadrupole time-of-flight mass spectrometry. Rapid Commun. 
Mass Spectrom. 25, 355–69. doi:10.1002/rcm.4860 
Farmaco, A.I. del, 2013. L’uso dei Farmaci in Italia. 
Ferrer, I., Thurman, E.M., 2012. Analysis of 100 pharmaceuticals and their degradates in water 
samples by liquid chromatography/quadrupole time-of-flight mass spectrometry. J. 
Chromatogr. A 1259, 148–57. doi:10.1016/j.chroma.2012.03.059 
Gómez, M.J., Gómez-Ramos, M.M., Malato, O., Mezcua, M., Férnandez-Alba, A.R., 2010. 
Rapid automated screening, identification and quantification of organic micro-
contaminants and their main transformation products in wastewater and river waters using 
liquid chromatography-quadrupole-time-of-flight mass spectrometry with an accurate-
mass . J. Chromatogr. A 1217, 7038–54. doi:10.1016/j.chroma.2010.08.070 
Gómez, M.J., Sirtori, C., Mezcua, M., Fernández-Alba, A.R., Agüera, A., 2008. 
Photodegradation study of three dipyrone metabolites in various water systems: 
Page	  19	  of	  25	  
	  
identification and toxicity of their photodegradation products. Water Res. 42, 2698–706. 
doi:10.1016/j.watres.2008.01.022 
Gonzalez-Mariño, I., Quintana, J.B., Rodriguez, I., Gonzalez-Diez, M., Cela, R., 2012. 
Screening and Selective Quantification of Illicit Drugs in Wastewater by Mixed-Mode 
Solid-Phase Extraction and Quadrupole-Time-of-Flight Liquid Chromatography–Mass 
Spectrometry. Anal. Chem. 84, 1708–1717. doi:10.1021/ac202989e 
Gracia-Lor, E., Sancho, J. V, Hernandez, F., 2011. Multi-class determination of around 50 
pharmaceuticals, including 26 antibiotics, in environmental and wastewater samples by 
ultra-high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. 
a 1218, 2264–2275. doi:10.1016/j.chroma.2011.02.026 
Gracia-Lor, E., Sancho, J. V, Hernandez, F., 2010. Simultaneous determination of acidic, 
neutral and basic pharmaceuticals in urban wastewater by ultra high-pressure liquid 
chromatography-tandem mass spectrometry. J. Chromatogr. a 1217, 622–632. 
doi:10.1016/j.chroma.2009.11.090 
Gracia-Lor, E., Sancho, J. V, Serrano, R., Hernandez, F., 2012. Occurrence and removal of 
pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of 
Valencia. Chemosphere 87, 453–462. doi:10.1016/j.chemosphere.2011.12.025 
Guidance document on analytical quality control and validation procedures for pesticides 
residues in food and feed [WWW Document], 2013. . SANCO /12571/2013. URL 
http://ec.europa.eu/food/plant/pesticides/guidance_documents/docs/qualcontrol_en.pdf 
Hernández, F., Bijlsma, L., Sancho, J. V, Díaz, R., Ibáñez, M., 2011. Rapid wide-scope 
screening of drugs of abuse, prescription drugs with potential for abuse and their 
metabolites in influent and effluent urban wastewater by ultrahigh pressure liquid 
chromatography-quadrupole-time-of-flight-mass spectrometry. Anal. Chim. Acta 684, 87–
97. doi:10.1016/j.aca.2010.10.043 
Hernández, F., Ibáñez, M., Bade, R., Bijlsma, L., Sancho, J.V., 2014. Investigation of 
pharmaceuticals and illicit drugs in waters by liquid chromatography-high-resolution mass 
spectrometry. TrAC Trends Anal. Chem. 63, 140–157. doi:10.1016/j.trac.2014.08.003 
Hernández, F., Ibáñez, M., Portolés, T., Cervera, M.I., Sancho, J. V, López, F.J., 2015. 
Advancing towards universal screening for organic pollutants in waters. J. Hazard. Mater. 
282, 86–95. doi:10.1016/j.jhazmat.2014.08.006 
Hernández, F., Sancho, J. V, Ibáñez, M., Abad, E., Portolés, T., Mattioli, L., 2012. Current use 
of high-resolution mass spectrometry in the environmental sciences. Anal. Bioanal. Chem. 
403, 1251–64. doi:10.1007/s00216-012-5844-7 
Horai, H., Arita, M., Kanaya, S., Nihei, Y., Ikeda, T., Suwa, K., Ojima, Y., Tanaka, K., Tanaka, 
S., Aoshima, K., Oda, Y., Kakazu, Y., Kusano, M., Tohge, T., Matsuda, F., Sawada, Y., 
Hirai, M.Y., Nakanishi, H., Ikeda, K., Akimoto, N., Maoka, T., Takahashi, H., Ara, T., 
Sakurai, N., Suzuki, H., Shibata, D., Neumann, S., Iida, T., Tanaka, K., Funatsu, K., 
Matsuura, F., Soga, T., Taguchi, R., Saito, K., Nishioka, T., 2010. MassBank: a public 
repository for sharing mass spectral data for life sciences. J. Mass Spectrom. 45, 703–14. 
doi:10.1002/jms.1777 
Ibáñez, M., Guerrero, C., Sancho, J. V., Hernández, F., 2009. Screening of antibiotics in surface 
and wastewater samples by ultra-high-pressure liquid chromatography coupled to hybrid 
Page	  20	  of	  25	  
	  
quadrupole time-of-flight mass spectrometry. J. Chromatogr. A 1216, 2529–39. 
doi:10.1016/j.chroma.2009.01.073 
Kasprzyk-Hordern, B., Dinsdale, R.M., Guwy, A.J., 2007. Multi-residue method for the 
determination of basic/neutral pharmaceuticals and illicit drugs in surface water by solid-
phase extraction and ultra performance liquid chromatography-positive electrospray 
ionisation tandem mass spectrometry. J. Chromatogr. A 1161, 132–45. 
doi:10.1016/j.chroma.2007.05.074 
Kosma, C.I., Lambropoulou, D.A., Albanis, T.A., 2014. Investigation of PPCPs in wastewater 
treatment plants in Greece: Occurrence, removal and environmental risk assessment. Sci. 
Total Environ. 466-467, 421–38. doi:10.1016/j.scitotenv.2013.07.044 
Krauss, M., Singer, H., Hollender, J., 2010. LC-high resolution MS in environmental analysis: 
from target screening to the identification of unknowns. Anal. Bioanal. Chem. 397, 943–
951. doi:10.1007/s00216-010-3608-9 
Kümmerer, K., 2009. Antibiotics in the aquatic environment--a review--part I. Chemosphere 75, 
417–34. doi:10.1016/j.chemosphere.2008.11.086 
Li, W.C., 2014. Occurrence, sources, and fate of pharmaceuticals in aquatic environment and 
soil. Environ. Pollut. 187, 193–201. doi:10.1016/j.envpol.2014.01.015 
Luo, Y., Guo, W., Ngo, H.H., Nghiem, L.D., Hai, F.I., Zhang, J., Liang, S., Wang, X.C., 2014. 
A review on the occurrence of micropollutants in the aquatic environment and their fate 
and removal during wastewater treatment. Sci. Total Environ. 473-474, 619–41. 
doi:10.1016/j.scitotenv.2013.12.065 
Metamizolo: una lunga storia tra luci ed ombre [WWW Document], n.d. URL 
http://www.farmacovigilanza.org/focus/200608/ 
Pal, R., Megharaj, M., Kirkbride, K.P., Naidu, R., 2013. Illicit drugs and the environment — A 
review. Sci. Total Environ. 463-464, 1079–1092. doi:10.1016/j.scitotenv.2012.05.086 
Pinhancos, R., Maass, S., Ramanathan, D.M., 2011. High-resolution mass spectrometry method 
for the detection, characterization and quantitation of pharmaceuticals in water. J. Mass 
Spectrom. 46, 1175–81. doi:10.1002/jms.2005 
Prescription data: IT del Sistema Nacional de Salud Volumen 30, N. 2/2006, 2006. Subgrupos 
ATC y Principios activos de mayor consumo en el Sistema Nacional de Salud en 2005 42–
49. 
Richardson, S.D., 2012. Environmental mass spectrometry: emerging contaminants and current 
issues. Anal. Chem. 84, 747–78. doi:10.1021/ac202903d 
Schymanski, E.L., Jeon, J., Gulde, R., Fenner, K., Ruff, M., Singer, H.P., Hollender, J., 2014. 
Identifying small molecules via high resolution mass spectrometry: Communicating 
confidence. Environ. Sci. Technol. doi:10.1021/es5002105 
SEWPROF ITN: A new paradigm in drug use and human health risk assessment: Sewage 
profiling at the community level [WWW Document], n.d. URL http://sewprof-itn.eu/ 
(accessed 6.1.15). 
Page	  21	  of	  25	  
	  
Wille, K., Claessens, M., Rappé, K., Monteyne, E., Janssen, C.R., De Brabander, H.F., 
Vanhaecke, L., 2011. Rapid quantification of pharmaceuticals and pesticides in passive 
samplers using ultra high performance liquid chromatography coupled to high resolution 
mass spectrometry. J. Chromatogr. A 1218, 9162–73. doi:10.1016/j.chroma.2011.10.039 
Zuccato, E., Castiglioni, S., Bagnati, R., Melis, M., Fanelli, R., 2010. Source, occurrence and 
fate of antibiotics in the Italian aquatic environment. J. Hazard. Mater. 179, 1042–8. 
doi:10.1016/j.jhazmat.2010.03.110 
Zuccato, E., Castiglioni, S., Fanelli, R., Reitano, G., Bagnati, R., Chiabrando, C., Pomati, F., 
Rossetti, C., Calamari, D., 2006. Pharmaceuticals in the environment in Italy: causes, 
occurrence, effects and control. Environ. Sci. Pollut. Res. Int. 13, 15–21. 
doi:10.1065/espr2006.01.004 
 
Page	  22	  of	  25	  
	  
Table 1: All compounds detected/identified in wastewater and surface water 
samples of Spain and Italy 
 
Compound Spain IWW (n=7) Spain EWW (n=7) Spain SW (n=5) Italy IWW (n=2) Italy EWW (n=2) 
 QTOF Orbitrap QTOF Orbitrap QTOF Orbitrap QTOF Orbitrap QTOF Orbitrap 
4-
aminoantipyrinea 
7/1b 6/5 7/7 7/3       
Acetaminophen 7/7 7/7 (7)c     2/2 2/2 (2)   
Atorvastatin   2/0 5/0       
Benzoylecgonine 7/7 7/7 7/7 (7) 7/7 1/0  2/2 (2) 2/2   
Bezafibrate  3/3 7/0 7/7   2/1 (1) 2/2  1/1 
Caffeinea,d 7/7 6/6 7/1 7/7 4/3 5/5 2/2 2/2   
Carbamazepine 3/0 7/7 7/7 7/7   2/2 2/1 2/2 2/2 
Ciprofloxacin 7/6 (6) 6/6 6/5 (5) 6/5   2/2 (2) 2/2   
Clarithromycin  1/0 5/5 (5) 6/6   2/1 (1) 2/1 2/1(1) 2/1 
Cocaine 7/3 (3) 3/3 2/0 1/0   2/2 (2) 1/1   
Codeine 7/7 (7) 7/7 7/4 (4) 6/6   2/1 (1) 2/1 2/1(1) 1/1 
Cotininea,d 7/6  7/7  2/0  2/0    
Diclofenac  3/3 7/7 7/7   2/2  2/2 2/2 2/2 
Enalapril 1/0          
Gabapentina 5/0  6/6      2/0  
Gemfibrozil        2/0   
Irbesartana 7/7 7/7 7/7 7/7 2/1 2/2 2/2 2/2 2/2 2/2 
Ketoprofen 7/6 (6) 6/5 6/2 2/2   2/2    
Morphine 7/0 4/4 2/0 4/4   2/0 2/2 2/0 2/0 
Moxifloxacin   2/0        
Naproxen 7/7 7/7 (3) 4/0    2/1 1/1 (1)   
Ofloxacin 7/3 7/7 7/7 7/7 1/0  2/2  2/2 2/2  2/2 
Oxazepama,d  3/3 7/7 5/5    1/1  1/0 
Sulfamethoxazole 3/2 (2) 6/6 7/5 5/4   2/2 (2) 2/2 2/1(1) 2/2 
Temazepama,d 3/3 (3) 6/5 7/5 7/7    1/0  1/1 
Trimethoprim 1/0  7/0 7/0   2/0  2/0 2/0 
Valsartana 7/7 7/7 7/7 7/7 2/0 3/3 2/2 2/2 1/1 2/2 
Venlafaxinea 7/7 (6) 7/7 7/7 7/7  1/0 2/0 2/2 2/2 2/2 
           
Total  21/16 23/18 25/18 21/18 6/2 4/4 20/16 20/16 12/9 12/10 
a: no reference standard for Orbitrap analysis 
b: number of compounds detected/identified	  
c: number in brackets refers to the number of samples manually checked in raw 
data for missing fragment ions 
d: no reference standard for QTOF analysis 
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Captions for Figures 
	  
Figure 1: (a): Identification of naproxen in an IWW sample by QTOF (ChromaLynx); 
LE spectrum shows the parent and fragment of naproxen (blue at 231.1017 and 
185.0971).  
(b): Identification of naproxen in the same IWW sample by Orbitrap (raw data, using 
QualBrowser) based on the fragment of 185.0961, compared with the standard (left).  
The QTOF data is from the single MSE injection, while the Orbitrap data is from the 
second MS/MS injection. 
	  
Figure 2: (a) Detection of bezafibrate in an EWW sample by QTOF (raw data). The 
XICs (left) and related mass spectrum (bottom) of the standard show the fragments 
(316.1104, 276.0791 and 138.9951), and mass errors. The sample (right) shows none of 
the related fragments at a similar peak shape or retention time to the precursor 
(362.1159).  
(b) Identification of bezafibrate in the same EWW sample (right) by Orbitrap 
(QualBrowser), compared with the standard (left). The fragment ions of 316.1102, 
276.0787 and 138.9946 are clear in both, as is the chromatographic peak at ~20.85 
minutes.  
The QTOF data is from the single MSE injection, while the Orbitrap data is from the 
second MS/MS injection. 
